(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3(Date:9/4/2008).../- BioForm Medical,Inc. (N...inical study of,Polidocanol, conducted in Germany ...USSLER & Co. GmbH (Kreussler), successfully met th... FDA as part of a New Drug Application,(NDA) proce...I (Efficacy and safety of,Aethoxysklerol compared ...
(Date:9/4/2008)...Lancet, and Presented at ESC Congress-, PHILADELP...ternational,study, the GISSI Heart Failure (GISSI-...ethyl esters reduced all cause mortality and hospi...nts with chronic heart,failure. These findings are...ancet, and were presented at the European Cardiova...
(Date:9/4/2008)...- Southern Research Institute,today a...IH) has selected,the organization to participate i...ction Center Network (MLPCN). The MLPCN -- a colla...lar Libraries Program which is,designed to benefit... human,genome and validate future targets for drug...
(Date:9/4/2008)...ber 4 /- Axentis Pharma AG has,initia...y and tolerability,of a new therapeutic formulatio...in cystic fibrosis patients. The new formulation a...ered directly to the site of,infection. The forthc...ifferent doses of the new drug. Initial results ar...
Breaking Medicine Technology:338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Jobson Medical Information LLC Acquires CenterWatch and New England IRB From Thomson Healthcare 9271 1Jobson Medical Information LLC Acquires CenterWatch and New England IRB From Thomson Healthcare 9271 2Hacker Joins Conseco as Senior Vice President and Treasurer 9269 1Torchmark Corporation Announces Fourth Quarter 2007 Earnings Release and Conference Call 9267 1Torchmark Corporation Announces Fourth Quarter 2007 Earnings Release and Conference Call 9267 2Hanger Orthopedic Group Inc Announces 2007 Year End Earnings Release Conference Call 9265 1Hanger Orthopedic Group Inc Announces 2007 Year End Earnings Release Conference Call 9265 2...cess with Positive Phase IIa Clinical,Trial Result...plication of Key,Product in AM-Pharma,s Pipeline ,....V., the,biopharmaceutical company developing nove...y diseases, today announced the positive,clinical ... trial,for patients with ulcerative colitis, a chr...
...E)--Jul 9, 2007 - Neose Technologies,Inc. (Nasdaq...he,C.E. Unterberg, Towbin Emerging Growth Opportun...el in New York City from July,10-12, 2007. The Com...T) on Tuesday, July 10, 2007. The presentation wil... following link:, http://www.wsw.com/webcast/ceut6...
Other Medicine Technology:AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 2AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 3AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 4AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 5Our 2.5v Ophthalmoscope Sets feature high-quality instruments, handles, and cases.
3.5v Ophthalmic Diagnostic Set with AutoStep Coaxial Ophthalmoscope, Spot Retinoscope, Rechargeable Handle, and Soft Case. High-quality eyecare from the preferred name in diagnostic instruments.
Quality and technological innovation are standard in all Welch Allyn diagnostic sets. Exclusively created for Optometry students, the 18335-SDS combines the superior optics of the 3.5V Coaxial-Plus O
High-quality eyecare from the preferred name in diagnostic instruments.
Medicine Products: